Not known Details About sodium phenobarbital solubility
Not known Details About sodium phenobarbital solubility
Blog Article
pentobarbital will minimize the extent or effect of erlotinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will lessen the level or effect of quinine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unknown.
If barbiturates are used throughout labor and supply, resuscitation devices needs to be out there. Facts are at this time not available to Examine the effect of those barbiturates when forceps supply or other intervention is necessary. Also, data are not readily available to determine the effect of those barbiturates over the afterwards advancement, improvement, and functional maturation of the kid.
Contraindicated (one)pentobarbital will lessen the extent or effect of naloxegol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Use of naloxegol with sturdy CYP3A4 inducers will not be recommended
pentobarbital will lessen the extent or effect of pimavanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Stay away from coadministration if possible. Keep an eye on for lowered pimavanserin efficacy. An increase in pimavanserin dosage might be desired.
pentobarbital will decrease the extent or effect of repaglinide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital raises toxicity of ifosfamide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. CYP3A4 inducers may possibly enhance the metabolism of ifosfamide to its active alkylating metabolites.
pentobarbital will minimize the extent or effect of alfentanil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unfamiliar.
pentobarbital will reduce the get more info level or effect of montelukast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known.
pentobarbital will minimize the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unknown.
On the other hand, the applying of those facts to other barbiturates appears valid and warrants serial blood level determinations of the related drugs when you'll find multiple therapies.
pentobarbital will decrease the extent or effect of nimodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.
pentobarbital will lower the level or effect of alosetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Mysterious.
pentobarbital will minimize the extent or effect of capivasertib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Strong or average CYP3A inducers lessen capivasertib exposure, which can lower efficacy.